Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| AramarkARMK · Entity 3359 | Director | June 09, 2021 | June 11, 2021 |
| CARDINAL HEALTH INCCAH · Entity 3014 | Director | November 09, 2020 | November 10, 2020 |
| TARGET CORPTGT · Entity 2967 | Director | March 10, 2021 | March 12, 2021 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Aramark
Report date June 09, 2021 · Filed June 11, 2021
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 16,799.117 |
Reported balance
After 2021-06-09 transaction · row 1
1 source rowRow 1 · 2021-06-09 · Grant · Acquired 49.502 · Balance 16,799.117 F1: Represents dividend equivalent rights in connection with the Issuer's quarterly dividend and accrued to the reporting person on deferred stock units held by the reporting person. These dividend equivalent rights vest on the same schedules as the underlying awards. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents dividend equivalent rights in connection with the Issuer's quarterly dividend and accrued to the reporting person on deferred stock units held by the reporting person. These dividend equivalent rights vest on the same schedules as the underlying awards.
CARDINAL HEALTH INC
Report date November 09, 2020 · Filed November 10, 2020
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common SharesSEC Table I · non-derivative | Direct | 39,616 |
Reported balance
After 2020-11-09 transaction · row 1
1 source rowRow 1 · 2020-11-09 · Grant · Acquired 3,339 · Balance 39,616 F1: Grant of restricted share units that will vest on November 9, 2021, except if the 2021 Annual Meeting of Shareholders is prior to November 9, 2021, then the restricted share units will vest on the date of the 2021 Annual Meeting of Shareholders. |
Filing footnotes · ownership attribution and instrument terms
F1: Grant of restricted share units that will vest on November 9, 2021, except if the 2021 Annual Meeting of Shareholders is prior to November 9, 2021, then the restricted share units will vest on the date of the 2021 Annual Meeting of Shareholders.
TARGET CORP
Report date March 10, 2021 · Filed March 12, 2021
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 36,497 |
Reported balance
After 2021-03-10 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2021-03-10 · Grant · Acquired 1,004 · Balance 36,497 F1: Award of restricted stock units pursuant to Target Corporation 2020 Long-Term Incentive Plan. F2: Includes dividend equivalents paid on restricted stock units since the date of the reporting person's last filing through the date of the reported transaction that have been reinvested in additional restricted stock units. |
Filing footnotes · ownership attribution and instrument terms
F1: Award of restricted stock units pursuant to Target Corporation 2020 Long-Term Incentive Plan.
F2: Includes dividend equivalents paid on restricted stock units since the date of the reporting person's last filing through the date of the reported transaction that have been reinvested in additional restricted stock units.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 09, 2021 Filed Jun 11, 2021 17:55 UTC | Aramark ARMK · Entity 3359 | GrantCommon Stock | 49.502 | $0.00 | $0.00 |
DisclosureSEC source: 0001584509-21-000132 · wf-form4_162344853421929.xml · nonDerivative · entry 1 DARDEN CALVIN · CIK 0001227732 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,799.117 F1 · shares: Represents dividend equivalent rights in connection with the Issuer's quarterly dividend and accrued to the reporting person on deferred stock units held by the reporting person. These dividend equivalent rights vest on the same schedules as the underlying awards. Read SEC document |
| March 10, 2021 Filed Mar 12, 2021 00:16 UTC | TARGET CORP TGT · Entity 2967 | GrantCommon Stock | 1,004 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-21-005139 · doc4.xml · nonDerivative · entry 1 DARDEN CALVIN · CIK 0001227732 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,497 F1 · kind: Award of restricted stock units pursuant to Target Corporation 2020 Long-Term Incentive Plan. F2 · balance_after: Includes dividend equivalents paid on restricted stock units since the date of the reporting person's last filing through the date of the reported transaction that have been reinvested in additional restricted stock units. Read SEC document |
| March 03, 2021 Filed Mar 5, 2021 19:30 UTC | Aramark ARMK · Entity 3359 | GrantCommon Stock | 45.224 | $0.00 | $0.00 |
DisclosureSEC source: 0001584509-21-000074 · wf-form4_161499059126672.xml · nonDerivative · entry 1 DARDEN CALVIN · CIK 0001227732 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,749.615 F1 · shares: Represents dividend equivalent rights in connection with the Issuer's quarterly dividend and accrued to the reporting person on deferred stock units held by the reporting person. These dividend equivalent rights vest on the same schedules as the underlying awards. Read SEC document |
| February 02, 2021 Filed Feb 4, 2021 18:06 UTC | Aramark ARMK · Entity 3359 | GrantCommon Stock | 4,518 | $0.00 | $0.00 |
DisclosureSEC source: 0001584509-21-000032 · wf-form4_161247996927992.xml · nonDerivative · entry 1 DARDEN CALVIN · CIK 0001227732 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,704.391 F1 · price: Represents a grant of deferred stock units, which will vest on the day prior to the first annual stockholders' meeting of the Company occurring after the grant date, subject to continued service, and, if vested, will be settled in shares of common stock on the first day of the seventh month after the date of the director's departure from the board. Read SEC document |
| December 08, 2020 Filed Dec 10, 2020 19:00 UTC | Aramark ARMK · Entity 3359 | GrantCommon Stock | 35.147 | $0.00 | $0.00 |
DisclosureSEC source: 0001584509-20-000261 · wf-form4_160764481375607.xml · nonDerivative · entry 1 DARDEN CALVIN · CIK 0001227732 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,186.391 F1 · shares: Represents dividend equivalent rights in connection with the Issuer's quarterly dividend and accrued to the reporting person on deferred stock units held by the reporting person. These dividend equivalent rights vest on the same schedules as the underlying awards. Read SEC document |
| November 09, 2020 Filed Nov 10, 2020 21:37 UTC | CARDINAL HEALTH INC CAH · Entity 3014 | GrantCommon Shares | 3,339 | $0.00 | $0.00 |
DisclosureSEC source: 0000721371-20-000154 · wf-form4_160504424926763.xml · nonDerivative · entry 1 DARDEN CALVIN · CIK 0001227732 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,616 F1 · shares: Grant of restricted share units that will vest on November 9, 2021, except if the 2021 Annual Meeting of Shareholders is prior to November 9, 2021, then the restricted share units will vest on the date of the 2021 Annual Meeting of Shareholders. Read SEC document |
| September 02, 2020 Filed Sep 3, 2020 19:30 UTC | Aramark ARMK · Entity 3359 | GrantCommon Stock | 45.979 | $0.00 | $0.00 |
DisclosureSEC source: 0001584509-20-000175 · wf-form4_159917580398863.xml · nonDerivative · entry 1 DARDEN CALVIN · CIK 0001227732 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,151.244 F1 · shares: Represents dividend equivalent rights in connection with the Issuer's quarterly dividend and accrued to the reporting person on deferred stock units held by the reporting person. These dividend equivalent rights vest on the same schedules as the underlying awards. Read SEC document |
| June 02, 2020 Filed Jun 4, 2020 17:34 UTC | Aramark ARMK · Entity 3359 | GrantCommon Stock | 49.966 | $0.00 | $0.00 |
DisclosureSEC source: 0001584509-20-000129 · wf-form4_159130644177616.xml · nonDerivative · entry 1 DARDEN CALVIN · CIK 0001227732 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,105.265 F1 · shares: Represents dividend equivalent rights in connection with the Issuer's quarterly dividend and accrued to the reporting person on deferred stock units held by the reporting person. These dividend equivalent rights vest on the same schedules as the underlying awards. Read SEC document |
| March 11, 2020 Filed Mar 14, 2020 00:18 UTC | TARGET CORP TGT · Entity 2967 | GrantCommon Stock | 1,711 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-20-005079 · doc4.xml · nonDerivative · entry 1 DARDEN CALVIN · CIK 0001227732 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,838 F1 · kind: Award of restricted stock units pursuant to the Amended and Restated Target Corporation 2011 Long-Term Incentive Plan. F2 · balance_after: Includes dividend equivalents paid on restricted stock units since the date of the reporting person's last filing through the date of the reported transaction that have been reinvested in additional restricted stock units. Read SEC document |
| February 27, 2020 Filed Mar 2, 2020 18:04 UTC | Aramark ARMK · Entity 3359 | GrantCommon Stock | 37.073 | $0.00 | $0.00 |
DisclosureSEC source: 0001584509-20-000065 · wf-form4_158319024271464.xml · nonDerivative · entry 1 DARDEN CALVIN · CIK 0001227732 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,055.299 F1 · shares: Represents dividend equivalent rights in connection with the Issuer's quarterly dividend and accrued to the reporting person on deferred stock units held by the reporting person. These dividend equivalent rights vest on the same schedules as the underlying awards. Read SEC document |
| January 29, 2020 Filed Jan 31, 2020 17:44 UTC | Aramark ARMK · Entity 3359 | GrantCommon Stock | 3,477 | $0.00 | $0.00 |
DisclosureSEC source: 0001584509-20-000028 · wf-form4_158051067619990.xml · nonDerivative · entry 1 DARDEN CALVIN · CIK 0001227732 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,018.226 F1 · price: Represents a grant of deferred stock units, which will vest on the day prior to the first annual stockholders' meeting of the Company occurring after the grant date, subject to continued service, and, if vested, will be settled in shares of common stock on the first day of the seventh month after the date of the director's departure from the board. Read SEC document |
| January 15, 2020 Filed Jan 16, 2020 21:32 UTC | CARDINAL HEALTH INC CAH · Entity 3014 | GrantPhantom Stock · Derivative | 115 | $52.45 | $6,031.75 |
DisclosureSEC source: 0000721371-20-000004 · wf-form4_157921032240654.xml · derivative · entry 1 DARDEN CALVIN · CIK 0001227732 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,114 Underlying: Common Shares · 115 shares Expires not disclosed F1 · derivative.exercise_price: Acquisition of shares of phantom stock under the Cardinal Health Deferred Compensation Plan that become payable in cash after the reporting person's termination of service as a director. Share amounts reported reflect the notional number of shares attributable to the reporting person's account under a unitized stock fund. F2 · price: Reflects closing price on prior business day. F1 · derivative.exercise_date: Acquisition of shares of phantom stock under the Cardinal Health Deferred Compensation Plan that become payable in cash after the reporting person's termination of service as a director. Share amounts reported reflect the notional number of shares attributable to the reporting person's account under a unitized stock fund. F1 · derivative.expiration_date: Acquisition of shares of phantom stock under the Cardinal Health Deferred Compensation Plan that become payable in cash after the reporting person's termination of service as a director. Share amounts reported reflect the notional number of shares attributable to the reporting person's account under a unitized stock fund. Read SEC document |
| December 09, 2019 Filed Dec 11, 2019 18:29 UTC | Aramark ARMK · Entity 3359 | GrantCommon Stock | 22.164 | $0.00 | $0.00 |
DisclosureSEC source: 0001584509-19-000255 · wf-form4_157610697754037.xml · nonDerivative · entry 1 DARDEN CALVIN · CIK 0001227732 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,541.226 F1 · shares: Represents dividend equivalent rights in connection with the Issuer's quarterly dividend and accrued to the reporting person on deferred stock units held by the reporting person. These dividend equivalent rights vest on the same schedules as the underlying awards. Read SEC document |
| November 12, 2019 Filed Nov 13, 2019 21:14 UTC | CARDINAL HEALTH INC CAH · Entity 3014 | GrantCommon Shares | 3,424 | $0.00 | $0.00 |
DisclosureSEC source: 0000721371-19-000143 · wf-form4_157367965068053.xml · nonDerivative · entry 1 DARDEN CALVIN · CIK 0001227732 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,277 F1 · shares: Grant of restricted share units that will vest on November 12, 2020, except if the 2020 Annual Meeting of Shareholders is prior to November 12, 2020, then the restricted share units will vest on the date of the 2020 Annual Meeting of Shareholders. Read SEC document |
| October 15, 2019 Filed Oct 17, 2019 20:39 UTC | CARDINAL HEALTH INC CAH · Entity 3014 | GrantPhantom Stock · Derivative | 122 | $46.78 | $5,707.16 |
DisclosureSEC source: 0000721371-19-000114 · wf-form4_157134473241597.xml · derivative · entry 1 DARDEN CALVIN · CIK 0001227732 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,441 Underlying: Common Shares · 122 shares Expires not disclosed F1 · derivative.exercise_price: Acquisition of shares of phantom stock under the Cardinal Health Deferred Compensation Plan that become payable in cash after the reporting person's termination of service as a director. Share amounts reported reflect the notional number of shares attributable to the reporting person's account under a unitized stock fund. F2 · price: Reflects closing price on prior business day. F1 · derivative.exercise_date: Acquisition of shares of phantom stock under the Cardinal Health Deferred Compensation Plan that become payable in cash after the reporting person's termination of service as a director. Share amounts reported reflect the notional number of shares attributable to the reporting person's account under a unitized stock fund. F1 · derivative.expiration_date: Acquisition of shares of phantom stock under the Cardinal Health Deferred Compensation Plan that become payable in cash after the reporting person's termination of service as a director. Share amounts reported reflect the notional number of shares attributable to the reporting person's account under a unitized stock fund. Read SEC document |
| August 29, 2019 Filed Sep 3, 2019 21:30 UTC | Aramark ARMK · Entity 3359 | GrantCommon Stock | 22.99 | $0.00 | $0.00 |
DisclosureSEC source: 0001584509-19-000176 · wf-form4_156756061034240.xml · nonDerivative · entry 1 DARDEN CALVIN · CIK 0001227732 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,519.062 F1 · shares: Represents dividend equivalent rights in connection with the Issuer's quarterly dividend and accrued to the reporting person on deferred stock units held by the reporting person. These dividend equivalent rights vest on the same schedules as the underlying awards. Read SEC document |
| July 15, 2019 Filed Jul 17, 2019 12:04 UTC | CARDINAL HEALTH INC CAH · Entity 3014 | GrantPhantom Stock · Derivative | 120 | $47.59 | $5,710.80 |
DisclosureSEC source: 0000721371-19-000053 · wf-form4_156336506865131.xml · derivative · entry 1 DARDEN CALVIN · CIK 0001227732 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,471 Underlying: Common Shares · 120 shares Expires not disclosed F1 · derivative.exercise_price: Acquisition of shares of phantom stock under the Cardinal Health Deferred Compensation Plan that become payable in cash after the reporting person's termination of service as a director. Share amounts reported reflect the notional number of shares attributable to the reporting person's account under a unitized stock fund. F2 · price: Reflects closing price on prior business day. F1 · derivative.exercise_date: Acquisition of shares of phantom stock under the Cardinal Health Deferred Compensation Plan that become payable in cash after the reporting person's termination of service as a director. Share amounts reported reflect the notional number of shares attributable to the reporting person's account under a unitized stock fund. F1 · derivative.expiration_date: Acquisition of shares of phantom stock under the Cardinal Health Deferred Compensation Plan that become payable in cash after the reporting person's termination of service as a director. Share amounts reported reflect the notional number of shares attributable to the reporting person's account under a unitized stock fund. Read SEC document |
| May 30, 2019 Filed Jun 3, 2019 18:20 UTC | Aramark ARMK · Entity 3359 | GrantCommon Stock | 26.702 | $0.00 | $0.00 |
DisclosureSEC source: 0001584509-19-000130 · wf-form4_155960039382622.xml · nonDerivative · entry 1 DARDEN CALVIN · CIK 0001227732 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,496.072 F1 · shares: Represents dividend equivalent rights in connection with the Issuer's quarterly dividend and accrued to the reporting person on deferred stock units held by the reporting person. These dividend equivalent rights vest on the same schedules as the underlying awards. Read SEC document |
| April 15, 2019 Filed Apr 17, 2019 12:19 UTC | CARDINAL HEALTH INC CAH · Entity 3014 | GrantPhantom Stock · Derivative | 122 | $46.79 | $5,708.38 |
DisclosureSEC source: 0000721371-19-000024 · wf-form4_155550353881225.xml · derivative · entry 1 DARDEN CALVIN · CIK 0001227732 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,348 Underlying: Common Shares · 122 shares Expires not disclosed F1 · derivative.exercise_price: Acquisition of shares of phantom stock under the Cardinal Health Deferred Compensation Plan that become payable in cash after the reporting person's termination of service as a director. Share amounts reported reflect the notional number of shares attributable to the reporting person's account under a unitized stock fund. F2 · price: Reflects closing price on prior business day. F1 · derivative.exercise_date: Acquisition of shares of phantom stock under the Cardinal Health Deferred Compensation Plan that become payable in cash after the reporting person's termination of service as a director. Share amounts reported reflect the notional number of shares attributable to the reporting person's account under a unitized stock fund. F1 · derivative.expiration_date: Acquisition of shares of phantom stock under the Cardinal Health Deferred Compensation Plan that become payable in cash after the reporting person's termination of service as a director. Share amounts reported reflect the notional number of shares attributable to the reporting person's account under a unitized stock fund. Read SEC document |
| March 13, 2019 Filed Mar 15, 2019 20:10 UTC | TARGET CORP TGT · Entity 2967 | GrantCommon Stock | 2,338 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-19-005344 · doc4.xml · nonDerivative · entry 1 DARDEN CALVIN · CIK 0001227732 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,287 F1 · kind: Award of restricted stock units pursuant to the Amended and Restated Target Corporation 2011 Long-Term Incentive Plan. F2 · balance_after: Includes dividend equivalents paid on restricted stock units since the date of the reporting person's last filing through the date of the reported transaction that have been reinvested in additional restricted stock units. Read SEC document |
| February 28, 2019 Filed Mar 4, 2019 16:42 UTC | Aramark ARMK · Entity 3359 | GrantCommon Stock | 30.636 | $0.00 | $0.00 |
DisclosureSEC source: 0001584509-19-000068 · wf-form4_155173576472825.xml · nonDerivative · entry 1 DARDEN CALVIN · CIK 0001227732 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,469.37 F1 · shares: Represents dividend equivalent rights in connection with the Issuer's quarterly dividend and accrued to the reporting person on deferred stock units held by the reporting person. These dividend equivalent rights vest on the same schedules as the underlying awards. Read SEC document |
| January 30, 2019 Filed Feb 1, 2019 16:36 UTC | Aramark ARMK · Entity 3359 | GrantCommon Stock | 4,908 | $0.00 | $0.00 |
DisclosureSEC source: 0001584509-19-000021 · wf-form4_154905698683298.xml · nonDerivative · entry 1 DARDEN CALVIN · CIK 0001227732 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,438.734 F1 · price: Represents a grant of deferred stock units, which will vest on the day prior to the first annual stockholders' meeting of the Company occurring after the grant date, subject to continued service, and, if vested, will be settled in shares of common stock on the first day of the seventh month after the date of the director's departure from the board. Read SEC document |
| January 15, 2019 Filed Jan 17, 2019 13:43 UTC | CARDINAL HEALTH INC CAH · Entity 3014 | GrantPhantom Stock · Derivative | 119 | $47.28 | $5,626.32 |
DisclosureSEC source: 0000721371-19-000004 · wf-form4_154773256870589.xml · derivative · entry 1 DARDEN CALVIN · CIK 0001227732 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,222 Underlying: Common Shares · 119 shares Expires not disclosed F1 · derivative.exercise_price: Acquisition of shares of phantom stock under the Cardinal Health Deferred Compensation Plan that become payable in cash after the reporting person's termination of service as a director. Share amounts reported reflect the notional number of shares attributable to the reporting person's account under a unitized stock fund. F2 · price: Reflects closing price on prior business day. F1 · derivative.exercise_date: Acquisition of shares of phantom stock under the Cardinal Health Deferred Compensation Plan that become payable in cash after the reporting person's termination of service as a director. Share amounts reported reflect the notional number of shares attributable to the reporting person's account under a unitized stock fund. F1 · derivative.expiration_date: Acquisition of shares of phantom stock under the Cardinal Health Deferred Compensation Plan that become payable in cash after the reporting person's termination of service as a director. Share amounts reported reflect the notional number of shares attributable to the reporting person's account under a unitized stock fund. Read SEC document |
| December 06, 2018 Filed Dec 10, 2018 17:06 UTC | Aramark ARMK · Entity 3359 | GrantCommon Stock | 10.286 | $0.00 | $0.00 |
DisclosureSEC source: 0001584509-18-000267 · wf-form4_154447957939637.xml · nonDerivative · entry 1 DARDEN CALVIN · CIK 0001227732 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,530.734 F1 · shares: Represents dividend equivalent rights in connection with the Issuer's quarterly dividend and accrued to the reporting person on deferred stock units held by the reporting person. These dividend equivalent rights vest on the same schedules as the underlying awards. Read SEC document |
| November 09, 2018 Filed Nov 13, 2018 22:24 UTC | CARDINAL HEALTH INC CAH · Entity 3014 | GrantCommon Shares | 3,164 | $0.00 | $0.00 |
DisclosureSEC source: 0000721371-18-000123 · wf-form4_154214782849526.xml · nonDerivative · entry 1 DARDEN CALVIN · CIK 0001227732 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,853 F1 · acquired: Grant of restricted share units that will vest on November 9, 2019, except if the 2019 Annual Meeting of Shareholders is prior to November 9, 2019, then the restricted share units will vest on the date of the 2019 Annual Meeting of Shareholders. Read SEC document |
| October 15, 2018 Filed Oct 16, 2018 21:14 UTC | CARDINAL HEALTH INC CAH · Entity 3014 | GrantPhantom Stock · Derivative | 106 | $51.63 | $5,472.78 |
DisclosureSEC source: 0000721371-18-000093 · wf-form4_153972445235692.xml · derivative · entry 1 DARDEN CALVIN · CIK 0001227732 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,091 Underlying: Common Shares · 106 shares Expires not disclosed F1 · derivative.exercise_price: Acquisition of shares of phantom stock under the Cardinal Health Deferred Compensation Plan that become payable in cash after the reporting person's termination of service as a director. Share amounts reported reflect the notional number of shares attributable to the reporting person's account under a unitized stock fund. F2 · price: Reflects closing price on prior business day. F1 · derivative.exercise_date: Acquisition of shares of phantom stock under the Cardinal Health Deferred Compensation Plan that become payable in cash after the reporting person's termination of service as a director. Share amounts reported reflect the notional number of shares attributable to the reporting person's account under a unitized stock fund. F1 · derivative.expiration_date: Acquisition of shares of phantom stock under the Cardinal Health Deferred Compensation Plan that become payable in cash after the reporting person's termination of service as a director. Share amounts reported reflect the notional number of shares attributable to the reporting person's account under a unitized stock fund. Read SEC document |
| August 30, 2018 Filed Sep 4, 2018 18:56 UTC | Aramark ARMK · Entity 3359 | GrantCommon Stock | 9.004 | $0.00 | $0.00 |
DisclosureSEC source: 0001584509-18-000172 · wf-form4_153610176358997.xml · nonDerivative · entry 1 DARDEN CALVIN · CIK 0001227732 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,520.448 F1 · shares: Represents dividend equivalent rights in connection with the Issuer's quarterly dividend and accrued to the reporting person on deferred stock units held by the reporting person. These dividend equivalent rights vest on the same schedules as the underlying awards. Read SEC document |
| August 09, 2018 Filed Aug 9, 2018 21:10 UTC | CARDINAL HEALTH INC CAH · Entity 3014 | GrantPhantom Stock · Derivative | 14 | $48.96 | $685.44 |
DisclosureSEC source: 0000721371-18-000055 · wf-form4_153384900714900.xml · derivative · entry 1 DARDEN CALVIN · CIK 0001227732 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,985 Underlying: Common Shares · 14 shares Expires not disclosed F1 · derivative.exercise_price: Acquisition of shares of phantom stock under the Cardinal Health Deferred Compensation Plan that become payable in cash after the reporting person's termination of service as a director. Share amounts reported reflect the notional number of shares attributable to the reporting person's account under a unitized stock fund. F2 · price: Reflects closing price on prior business day. F1 · derivative.exercise_date: Acquisition of shares of phantom stock under the Cardinal Health Deferred Compensation Plan that become payable in cash after the reporting person's termination of service as a director. Share amounts reported reflect the notional number of shares attributable to the reporting person's account under a unitized stock fund. F1 · derivative.expiration_date: Acquisition of shares of phantom stock under the Cardinal Health Deferred Compensation Plan that become payable in cash after the reporting person's termination of service as a director. Share amounts reported reflect the notional number of shares attributable to the reporting person's account under a unitized stock fund. Read SEC document |
| July 16, 2018 Filed Jul 16, 2018 20:41 UTC | CARDINAL HEALTH INC CAH · Entity 3014 | GrantPhantom Stock · Derivative | 98 | $50.80 | $4,978.40 |
DisclosureSEC source: 0000721371-18-000051 · wf-form4_153177366084292.xml · derivative · entry 1 DARDEN CALVIN · CIK 0001227732 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,973 Underlying: Common Shares · 98 shares Expires not disclosed F1 · derivative.exercise_price: Acquisition of shares of phantom stock under the Cardinal Health Deferred Compensation Plan that become payable in cash after the reporting person's termination of service as a director. Share amounts reported reflect the notional number of shares attributable to the reporting person's account under a unitized stock fund. F2 · price: Reflects closing price on prior business day. F1 · derivative.exercise_date: Acquisition of shares of phantom stock under the Cardinal Health Deferred Compensation Plan that become payable in cash after the reporting person's termination of service as a director. Share amounts reported reflect the notional number of shares attributable to the reporting person's account under a unitized stock fund. F1 · derivative.expiration_date: Acquisition of shares of phantom stock under the Cardinal Health Deferred Compensation Plan that become payable in cash after the reporting person's termination of service as a director. Share amounts reported reflect the notional number of shares attributable to the reporting person's account under a unitized stock fund. Read SEC document |
| May 31, 2018 Filed Jun 4, 2018 18:11 UTC | Aramark ARMK · Entity 3359 | GrantCommon Stock | 9.472 | $0.00 | $0.00 |
DisclosureSEC source: 0001584509-18-000119 · wf-form4_152815028327842.xml · nonDerivative · entry 1 DARDEN CALVIN · CIK 0001227732 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,511.444 F1 · shares: Represents dividend equivalent rights in connection with the Issuer's quarterly dividend and accrued to the reporting person on deferred stock units held by the reporting person. These dividend equivalent rights vest on the same schedules as the underlying awards. Read SEC document |
| April 16, 2018 Filed Apr 17, 2018 20:44 UTC | CARDINAL HEALTH INC CAH · Entity 3014 | GrantPhantom Stock · Derivative | 82 | $60.42 | $4,954.44 |
DisclosureSEC source: 0000721371-18-000032 · wf-form4_152399787104883.xml · derivative · entry 1 DARDEN CALVIN · CIK 0001227732 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,859 Underlying: Common Shares · 82 shares Expires not disclosed F1 · derivative.exercise_price: Acquisition of shares of phantom stock under the Cardinal Health Deferred Compensation Plan that become payable in cash after the reporting person's termination of service as a director. Share amounts reported reflect the notional number of shares attributable to the reporting person's account under a unitized stock fund. F1 · derivative.exercise_date: Acquisition of shares of phantom stock under the Cardinal Health Deferred Compensation Plan that become payable in cash after the reporting person's termination of service as a director. Share amounts reported reflect the notional number of shares attributable to the reporting person's account under a unitized stock fund. F1 · derivative.expiration_date: Acquisition of shares of phantom stock under the Cardinal Health Deferred Compensation Plan that become payable in cash after the reporting person's termination of service as a director. Share amounts reported reflect the notional number of shares attributable to the reporting person's account under a unitized stock fund. Read SEC document |
| March 14, 2018 Filed Mar 16, 2018 21:04 UTC | TARGET CORP TGT · Entity 2967 | GrantCommon Stock | 2,538 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-18-006307 · doc4.xml · nonDerivative · entry 1 DARDEN CALVIN · CIK 0001227732 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,951 F1 · kind: Award of restricted stock units pursuant to the Amended and Restated Target Corporation 2011 Long-Term Incentive Plan. F2 · balance_after: Includes dividend equivalents paid on restricted stock units since the date of the reporting person's last filing through the date of the reported transaction that have been reinvested in additional restricted stock units. Read SEC document |
| March 01, 2018 Filed Mar 5, 2018 16:52 UTC | Aramark ARMK · Entity 3359 | GrantCommon Stock | 8.972 | $0.00 | $0.00 |
DisclosureSEC source: 0001584509-18-000064 · wf-form4_152028672819970.xml · nonDerivative · entry 1 DARDEN CALVIN · CIK 0001227732 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,501.972 F1 · shares: Represents dividend equivalent rights in connection with the Issuer's quarterly dividend and accrued to the reporting person on deferred stock units held by the reporting person. These dividend equivalent rights vest on the same schedules as the underlying awards. Read SEC document |
| January 31, 2018 Filed Feb 2, 2018 16:14 UTC | Aramark ARMK · Entity 3359 | GrantCommon Stock | 3,493 | $0.00 | $0.00 |
DisclosureSEC source: 0001584509-18-000030 · wf-form4_151760604657958.xml · nonDerivative · entry 1 DARDEN CALVIN · CIK 0001227732 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,493 F1 · price: Represents a grant of deferred stock units, which will vest on the day prior to the first annual stockholders' meeting of the Company occurring after the grant date, subject to continued service, and, if vested, will be settled in shares of common stock on the first day of the seventh month after the date of the director's departure from the board. Read SEC document |
| January 16, 2018 Filed Jan 17, 2018 21:12 UTC | CARDINAL HEALTH INC CAH · Entity 3014 | GrantPhantom Stock · Derivative | 69 | $71.49 | $4,932.81 |
DisclosureSEC source: 0000721371-18-000013 · wf-form4_151622354491501.xml · derivative · entry 1 DARDEN CALVIN · CIK 0001227732 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,760 Underlying: Common Shares · 69 shares Expires not disclosed F1 · derivative.exercise_price: Acquisition of shares of phantom stock under the Cardinal Health Deferred Compensation Plan that become payable in cash after the reporting person's termination of service as a director. Share amounts reported reflect the notional number of shares attributable to the reporting person's account under a unitized stock fund. F2 · price: Price is closing share price on January 12, 2018. F1 · derivative.exercise_date: Acquisition of shares of phantom stock under the Cardinal Health Deferred Compensation Plan that become payable in cash after the reporting person's termination of service as a director. Share amounts reported reflect the notional number of shares attributable to the reporting person's account under a unitized stock fund. F1 · derivative.expiration_date: Acquisition of shares of phantom stock under the Cardinal Health Deferred Compensation Plan that become payable in cash after the reporting person's termination of service as a director. Share amounts reported reflect the notional number of shares attributable to the reporting person's account under a unitized stock fund. Read SEC document |
| November 08, 2017 Filed Nov 9, 2017 22:20 UTC | CARDINAL HEALTH INC CAH · Entity 3014 | GrantCommon Shares | 2,623 | $0.00 | $0.00 |
DisclosureSEC source: 0000721371-17-000147 · wf-form4_151026601218754.xml · nonDerivative · entry 1 DARDEN CALVIN · CIK 0001227732 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,689 F1 · shares: Grant of restricted share units that will vest on November 8, 2018, except if the 2018 Annual Meeting of Shareholders is prior to November 8, 2018, then restricted share units will vest on the date of the 2018 Annual Meeting of Shareholders. Read SEC document |
| October 16, 2017 Filed Oct 17, 2017 21:12 UTC | CARDINAL HEALTH INC CAH · Entity 3014 | GrantPhantom Stock · Derivative | 76 | $64.96 | $4,936.96 |
DisclosureSEC source: 0000721371-17-000132 · wf-form4_150827473567422.xml · derivative · entry 1 DARDEN CALVIN · CIK 0001227732 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,690 Underlying: Common Shares · 76 shares Expires not disclosed F1 · derivative.exercise_price: Acquisition of shares of phantom stock under the Cardinal Health Deferred Compensation Plan that become payable in cash after the reporting person's termination of service as a director. Share amounts reported reflect the notional number of shares attributable to the reporting person's account under a unitized stock fund. F2 · price: Price is closing share price on October 13, 2017. F1 · derivative.exercise_date: Acquisition of shares of phantom stock under the Cardinal Health Deferred Compensation Plan that become payable in cash after the reporting person's termination of service as a director. Share amounts reported reflect the notional number of shares attributable to the reporting person's account under a unitized stock fund. F1 · derivative.expiration_date: Acquisition of shares of phantom stock under the Cardinal Health Deferred Compensation Plan that become payable in cash after the reporting person's termination of service as a director. Share amounts reported reflect the notional number of shares attributable to the reporting person's account under a unitized stock fund. Read SEC document |
| July 17, 2017 Filed Jul 17, 2017 20:56 UTC | CARDINAL HEALTH INC CAH · Entity 3014 | GrantPhantom Stock · Derivative | 64 | $78.11 | $4,999.04 |
DisclosureSEC source: 0000721371-17-000048 · wf-form4_150032499974273.xml · derivative · entry 1 DARDEN CALVIN · CIK 0001227732 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,597 Underlying: Common Shares · 64 shares Expires not disclosed F1 · derivative.exercise_price: Acquisition of shares of phantom stock under the Cardinal Health Deferred Compensation Plan that become payable in cash after the reporting person's termination of service as a director. Share amounts reported reflect the notional number of shares attributable to the reporting person's account under a unitized stock fund. F2 · price: Price is closing share price on July 14, 2017. F1 · derivative.exercise_date: Acquisition of shares of phantom stock under the Cardinal Health Deferred Compensation Plan that become payable in cash after the reporting person's termination of service as a director. Share amounts reported reflect the notional number of shares attributable to the reporting person's account under a unitized stock fund. F1 · derivative.expiration_date: Acquisition of shares of phantom stock under the Cardinal Health Deferred Compensation Plan that become payable in cash after the reporting person's termination of service as a director. Share amounts reported reflect the notional number of shares attributable to the reporting person's account under a unitized stock fund. Read SEC document |
| April 17, 2017 Filed Apr 17, 2017 20:34 UTC | CARDINAL HEALTH INC CAH · Entity 3014 | GrantPhantom Stock · Derivative | 61 | $81.43 | $4,967.23 |
DisclosureSEC source: 0000721371-17-000026 · wf-form4_149246125378170.xml · derivative · entry 1 DARDEN CALVIN · CIK 0001227732 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,526 Underlying: Common Shares · 61 shares Expires not disclosed F1 · derivative.exercise_price: Acquisition of shares of phantom stock under the Cardinal Health Deferred Compensation Plan that become payable in cash after the reporting person's termination of service as a director. Share amounts reported reflect the notional number of shares attributable to the reporting person's account under a unitized stock fund. F2 · price: Price is closing share price on April 13, 2017. F1 · derivative.exercise_date: Acquisition of shares of phantom stock under the Cardinal Health Deferred Compensation Plan that become payable in cash after the reporting person's termination of service as a director. Share amounts reported reflect the notional number of shares attributable to the reporting person's account under a unitized stock fund. F1 · derivative.expiration_date: Acquisition of shares of phantom stock under the Cardinal Health Deferred Compensation Plan that become payable in cash after the reporting person's termination of service as a director. Share amounts reported reflect the notional number of shares attributable to the reporting person's account under a unitized stock fund. Read SEC document |
| January 16, 2017 Filed Jan 17, 2017 21:21 UTC | CARDINAL HEALTH INC CAH · Entity 3014 | GrantPhantom Stock · Derivative | 66 | $75.00 | $4,950.00 |
DisclosureSEC source: 0000721371-17-000006 · wf-form4_148468806010756.xml · derivative · entry 1 DARDEN CALVIN · CIK 0001227732 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,470 Underlying: Common Shares · 66 shares Expires not disclosed F1 · derivative.exercise_price: Acquisition of shares of phantom stock under the Cardinal Health Deferred Compensation Plan that become payable in cash after the reporting person's termination of service as a director. Share amounts reported reflect the notional number of shares attributable to the reporting person's account under a unitized stock fund. F2 · price: Price is closing share price on January 13, 2017. F1 · derivative.exercise_date: Acquisition of shares of phantom stock under the Cardinal Health Deferred Compensation Plan that become payable in cash after the reporting person's termination of service as a director. Share amounts reported reflect the notional number of shares attributable to the reporting person's account under a unitized stock fund. F1 · derivative.expiration_date: Acquisition of shares of phantom stock under the Cardinal Health Deferred Compensation Plan that become payable in cash after the reporting person's termination of service as a director. Share amounts reported reflect the notional number of shares attributable to the reporting person's account under a unitized stock fund. Read SEC document |
| January 11, 2017 Filed Jan 13, 2017 18:30 UTC | TARGET CORP TGT · Entity 2967 | GrantCommon Stock | 2,377 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-17-001071 · doc4.xml · nonDerivative · entry 1 DARDEN CALVIN · CIK 0001227732 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,080 F1 · kind: Award of restricted stock units pursuant to the Amended and Restated Target Corporation 2011 Long-Term Incentive Plan. F2 · balance_after: Includes dividend equivalents paid on restricted stock units since the date of the reporting person's last filing through the date of the reported transaction that have been reinvested in additional restricted stock units. Read SEC document |
| November 03, 2016 Filed Nov 7, 2016 13:20 UTC | CARDINAL HEALTH INC CAH · Entity 3014 | GrantCommon Shares | 2,447 | $0.00 | $0.00 |
DisclosureSEC source: 0000721371-16-000346 · wf-form4_147852483802531.xml · nonDerivative · entry 1 DARDEN CALVIN · CIK 0001227732 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,066 F1 · shares: Grant of restricted share units that will vest on November 3, 2017, except if the 2017 Annual Meeting of Shareholders is prior to November 3, 2017, then the restricted share units will vest on the date of the 2017 Annual Meeting of Shareholders. Read SEC document |
| October 17, 2016 Filed Oct 18, 2016 12:38 UTC | CARDINAL HEALTH INC CAH · Entity 3014 | GrantPhantom Stock · Derivative | 66 | $75.27 | $4,967.82 |
DisclosureSEC source: 0000721371-16-000317 · wf-form4_147679429082138.xml · derivative · entry 1 DARDEN CALVIN · CIK 0001227732 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,404 Underlying: Common Shares · 66 shares Expires not disclosed F1 · derivative.exercise_price: Acquisition of shares of phantom stock under the Cardinal Health Deferred Compensation Plan that become payable in cash after the reporting person's termination of service as a director. Share amounts reported reflect the notional number of shares attributable to the reporting person's account under a unitized stock fund. F2 · price: Price is closing share price on October 14, 2016. F1 · derivative.exercise_date: Acquisition of shares of phantom stock under the Cardinal Health Deferred Compensation Plan that become payable in cash after the reporting person's termination of service as a director. Share amounts reported reflect the notional number of shares attributable to the reporting person's account under a unitized stock fund. F1 · derivative.expiration_date: Acquisition of shares of phantom stock under the Cardinal Health Deferred Compensation Plan that become payable in cash after the reporting person's termination of service as a director. Share amounts reported reflect the notional number of shares attributable to the reporting person's account under a unitized stock fund. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.